Elizabeth Johnson, Mackenzie Schoonmaker, Amanda Thompson Beveridge & Diamond PC Key Takeaways What Happened: The Food and Drug Administration (FDA) finalized a 2020 draft guidance detailing the agency’s recommendations for clinical research for developing...
By Oliver Serafini, Tommy Tobin & Barak Cohen on January 27, 2023 The District Court for the Western District of New York denied a motion on January 6, 2023, to dismiss claims alleging that a publicly traded company misled investors regarding an investigation by...
24 January 2023 by Alexandra Avvocato (New York) Morrison & Foerster LLP This week, the Court addresses whether plaintiffs may bring civil RICO claims that allege injury to a business that violates federal law. FRANCINE SHULMAN ET AL. V. TODD KAPLAN ET AL. The...
Ninth Circuit Affirms Dismissal of RICO Claims Relating to Cannabis Well, it looks like cannabis RICO lawsuits are not going to happen any time soon. As an update to this post I wrote in 2020, the Ninth Circuit has just affirmed the dismissal of two RICO claims...
If you give me an opportunity to quote George Harrison, I’m going to do it. In “Taxman,” he wrote: Should five percent appear too small Be thankful I don’t take it all ‘Cause I’m the taxman Yeah, I’m the taxman I suspect “The Quiet One” would be appalled to know the...
Cannabis advertising has always been a precarious art. From first amendment commercial speech issues to zealous state marketing and promotion regulations to false claim lawsuits, cannabis advertising can go down some dark rabbit holes. Notoriously, tech giants...